NORFOLK AND WAVENEY STP THERAPEUTICS ADVISORY GROUP (TAG) SHARED CARE AGREEMENTShared Care Agreement • November 10th, 2023
Contract Type FiledNovember 10th, 2023Generic and Proprietary/Brand Name IM Testosterone esters - Sustanon 250®Oral Testosterone undecanoateSustanon 250® Restandol® Testocaps® Indications for shared care This shared care agreement is to support primary care with the management of boys with absent/delayed puberty requiring exogenous testosterone therapy under the care and supervision of paediatric endocrinologists. This includes boys with hypogonadotropic hypogonadism (HH) of various etiologies, androgen deficiency secondary to testicular failure (hyper gonadotrophic hypogonadism) of various etiology, and constitutional delay of growth and puberty (CDGP). The aim of testosterone replacement therapy is to mimic the normal pattern of puberty and mimic requirements at different stages of pubertal development. This guideline aims to provide the clinician withtestosterone dosing regimens for pubertal induction, progression and post-pubertal maintenance. Specialist Prescribing and Monitoring Responsibilities – summary. Full detai